The Nevada-based company is specialized in the advanced science of tissue culture. Pharmagreen offers premium growing services that enhance plants’ preservation and quality. The company has four primary services: 

• A pharma-grade quality cannabis flower tops and biomass production that will produce the highest quality raw material of cannabis from its state-of-the-art greenhouse;
• A tissue cultured starter plantlet production that guarantees no genetic drift, bugs, and diseases; 
• A cultivation schedule  optimizing deeding and fertilizing programs for specific strains based on the growing environment and lighting system, adding a level of security to any growth strategy;
• Cold storage of tissue culture using suspended growth state technology enables cultivators to preserve their strains’ lives, preventing genetic drift, contamination, bugs, and diseases.

Pharmagreen’s solution brings many opportunities. Irs IoT facility reduces disease and contamination of plants, and the company can supply up to a million starter plantlets with reduced growing time and more space for flowers, increasing the frequency of production cycles and yielding higher profits in return. 

The company is currently building a 12,000 sq ft greenhouse utilizing IoT technologies for Cannabis productions and is targeting to increase its current gross annual revenue from $500k to $9M. In the short-term future, Pharmagreen intends to expand its production of flower tops and sales of tissue starter plantlets, sell in-house pharma-grade cannabis oils and derivatives under the Pharmagreen brand, and build a tissue culture starter plantlets production facility to supply in-house greenhouse needs and for third-part sales.